REPORT DESCRIPTION
Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3
Billion Globally in 20...
Browse Report : Artificial Vital Organs and Medical Bionics Market
able to keep pace with an increase in demand for effici...
o Artificial Liver
o Artificial Pancreas
 Insulin Pumps
o Artificial Lungs
 Heart-Lung Bypass Machine
 Oxygenators
 Me...
 Europe
 Asia-Pacific
 Rest of the World (RoW)
Browse the full report at http://www.transparencymarketresearch.com/arti...
3.6.2 Bargaining Power of Buyers
3.6.3 Threat from Substitutes
3.6.4 Threat of New Entrants
3.6.5 Degree of Competitive Ri...
4.3.5 Brain Bionics
4.3.5.1 Spinal Cord Stimulators
Browse the full report at http://www.transparencymarketresearch.com/ar...
5.5.1 Row Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 –
2018 (USD Million)
Chapter 6 Compe...
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Strategic Overview
Browse the full report at http://www.transparenc...
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Strategic Overview
8.7.5 Recent Developments
8.8 F. Hoffmann-La Roc...
8.11.5 Recent Developments
8.12 Jarvik Heart, Inc.
8.12.1 Company Overview
Browse the full report at http://www.transparen...
8.15.5 Recent Developments
8.16 Ossur Hf
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4...
8.20.2 Financial Overview
8.20.3 Product Portfolio
8.20.4 Strategic Overview
8.20.5 Recent Developments
8.21 Touch Bionics...
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources ...
Upcoming SlideShare
Loading in …5
×

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 :Transparency Market Research

332 views

Published on

According to a new market research report published by Transparency Market Research “Artificial Vital Organs and Medical Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," in 2011, the artificial vital organs and medical bionics market was valued at USD 17.5 billion and it is expected to grow at a CAGR of 9.2% from 2012 to 2018, to reach an estimated value of USD 32.3 billion in 2018.


Browse Report : http://www.transparencymarketresearch.com/artificial-vital-organs-medical-bionics.html

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
332
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 :Transparency Market Research

  1. 1. REPORT DESCRIPTION Artificial Vital Organs and Medical Bionics Market is Expected to Reach USD 32.3 Billion Globally in 2018 According to a new market research report published by Transparency Market Research “Artificial Vital Organs and Medical Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," in 2011, the artificial vital organs and medical bionics market was valued at USD 17.5 billion and it is expected to grow at a CAGR of 9.2% from 2012 to 2018, to reach an estimated value of USD 32.3 billion in 2018. An artificial organ is a man-made device, which is integrated or implanted into the patient, to replace an original diseased organ and restore its specific function. Medical bionics is the study of application of mechanics and electronics to replace a limb or other part of a functional organ that is mechanically powered. With rapid development in healthcare technology, organ transplantation has evolved as a common surgical practice. With years of extensive research and development in the field of medical devices and related technological innovations, artificial vital organs and medical bionics are successfully established as viable alternatives for the replacement of donor organs as the latter are not Transparency Market Research Artificial Vital Organs and Medical Bionics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018 Single User License: US $ 4595 Multi User License: US $ 7595 Corporate User License: US $ 10595 Buy Now Request Sample Published Date: June 2013 139 Pages Report
  2. 2. Browse Report : Artificial Vital Organs and Medical Bionics Market able to keep pace with an increase in demand for efficient rehabilitation of the physically challenged. The global artificial vital organs market is segmented into artificial heart, kidney, lungs, liver and pancreas markets. The market for artificial vital organs is led by the artificial kidney segment, in terms of revenue. Increase in prevalence of renal disorders and acute renal failure due to the sedentary lifestyle is a major driver for this market. Increase in the prevalence of cardiovascular diseases leading to acute cardiac failure has led to a growing need for heart replacement. Also, the number of patients awaiting transplant are far more than the availability of donor organs and this has led to an increase in the demand for total artificial heart (TAH). The market for total artificial heart is expected to grow at a CAGR of more than 9% from 2012 to 2018. The medical bionics market is categorized into ear bionics (cochlear implants), vision bionics, exoskeletons, bionic limbs, brain bionics and cardiac bionics. High prevalence of occupation and age-related disabilities demands novel methods of patient rehabilitation to offer a better life for such patients. The market for exoskeletons is expected to emerge as the fastest growing segment, at a CAGR of over 15% from 2012 to 2018. Geographically, North America leads the market for artificial vital organs and medical bionics. Aging of the baby boomer population and the corresponding rise in prevalence of acute cases of cardiovascular diseases, renal diseases and respiratory disorders, and the increase in prevalence of age-related disorders and occupation-related disabilities are the major drivers for the growth in demand for artificial organs in North America. However, improvement in healthcare expenditure and healthcare infrastructure and rising scope of medical tourism will increase the market share of Asia-Pacific in the future. The key players in the artificial vital organs and medical bionics market include Abbott Diabetes Care, Abiomed, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc., Gambro AB, Medtronic, Inc., Nikkiso Co., Ltd., SynCardia Systems, Inc., Ossur Hf, WorldHeart Corporation, Ekso Bionics, Touch Bionics, Ottobock Healthcare Gmbh, Second Sight Medical Products, Inc. and others. The global artificial vital organs and medical bionics market is segmented as follows: Artificial Vital Organs and Medical Bionics Market, by Product Types  Artificial Vital Organs Market o Artificial Heart  Total Artificial Heart o Artificial Kidney  Hemodialysis Machines
  3. 3. o Artificial Liver o Artificial Pancreas  Insulin Pumps o Artificial Lungs  Heart-Lung Bypass Machine  Oxygenators  Medical Bionics Market o Ear Bionics (Cochlear implants) o Vision Bionics o Exoskeletons o Bionic Limbs  Bionic Leg  Bionic Hand o Brain Bionics  Spinal Cord Stimulators  Deep Brain Stimulators  Vagus Nerve Stimulators o Cardiac Bionics  Ventricular Assist Devices (VAD)  Left Ventricular Assist Device (LVAD)  Right Ventricular Assist Device (RVAD)  Heart Valves  Mechanical Heart Valves  Biological Tissue Valves  Transcatheter Heart Valves Artificial Vital Organs and Medical Bionics Market, by Geography  North America
  4. 4.  Europe  Asia-Pacific  Rest of the World (RoW) Browse the full report at http://www.transparencymarketresearch.com/artificial- vital-organs-medical-bionics.html TABLE OF CONTENTS Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations Chapter 2 Executive Summary Chapter 3 Global Artificial Vital Organs and Medical Bionics Market Overview 3.1 Introduction 3.2 Market Trends and Future Outlook 3.3 Market Drivers 3.3.1 Increase in Prevalence of Organ Failure and Disabilities 3.3.2 Increase in the Number of Patients for Organ Transplant and Lack Of Donor Organs 3.4 Market Restraints 3.4.1 Criticism Associated with Artificial Organ Transplant 3.4.2 High Cost Involved in Development of Artificial Organs and Medical Bionics 3.5 Market Opportunities 3.5.1 Scope Of Artificial Organs in Therapeutics 3.6 Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market 3.6.1 Bargaining Power of Suppliers
  5. 5. 3.6.2 Bargaining Power of Buyers 3.6.3 Threat from Substitutes 3.6.4 Threat of New Entrants 3.6.5 Degree of Competitive Rivalry 3.7 Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography Chapter 4 Global Artificial Vital Organs and Medical Bionics Market, By Product Type 4.1 Overview 4.2 Artificial Vital Organs Market 4.2.1 Artificial Heart 4.2.1.1 Total Artificial Heart (TAH) 4.2.2 Artificial Kidney 4.2.2.1 Hemodialysis Machines 4.2.3 Artificial Liver 4.2.4 Artificial Pancreas 4.2.4.1 Insulin Pumps 4.2.5 Artificial Lungs 4.2.5.1 Heart-Lung Bypass Machines 4.2.5.2 Oxygenators 4.3 Bionics Market 4.3.1 Ear Bionics (Cochlear Implants) 4.3.2 Vision Bionics 4.3.3 Exoskeletons 4.3.4 Bionic Limbs 4.3.4.1 Bionic Leg 4.3.4.2 Bionic Hand
  6. 6. 4.3.5 Brain Bionics 4.3.5.1 Spinal Cord Stimulators Browse the full report at http://www.transparencymarketresearch.com/artificial- vital-organs-medical-bionics.html 4.3.5.2 Deep Brain Stimulators 4.3.5.3 Vagus Nerve Stimulators 4.3.6 Cardiac Bionics 4.3.6.1 Ventricular Assist Device (VAD) 4.3.6.2 Left Ventricular Assist Device (LVAD) 4.3.6.3 Right Ventricular Assist Device (RVAD) 4.3.6.4 Heart Valves 4.3.6.4.1 Mechanical Heart Valves 4.3.6.4.2 Biological Tissue Valves 4.3.6.4.3 Transcatheter Heart Valves Chapter 5 Global Artificial Vital Organs and Medical Bionics Market, By Geography 5.1 Introduction 5.2 North America 5.2.1 North America Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million) 5.3 Europe 5.3.1 Europe Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million) 5.5 Rest of the World (Row)
  7. 7. 5.5.1 Row Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010 – 2018 (USD Million) Chapter 6 Competitive Landscape 6.1 Current Market Scenario and Pipeline Snapshot Chapter 7 Recommendations 7.1 Market Strategy for Success 7.2 Barriers to be Considered 7.2.1 Financial Constraints 7.2.2 Regulatory Approvals Chapter 8 Company Profiles 8.1 Abbott Diabetes Care, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Strategic Overview 8.1.5 Recent Developments 8.2 Abiomed, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Strategic Overview 8.2.5 Recent Developments 8.3 Asahi Kasei Medical Co., Ltd. 8.3.1 Company Overview
  8. 8. 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Strategic Overview Browse the full report at http://www.transparencymarketresearch.com/artificial- vital-organs-medical-bionics.html 8.3.5 Recent Developments 8.4 Baxter International, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Strategic Overview 8.4.5 Recent Developments 8.5 Cyberonics, Inc. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Strategic Overview 8.5.5 Recent Developments 8.6 Edwards Lifesciences Corporation 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Strategic Overview 8.6.5 Recent Developments 8.7 Ekso Bionics 8.7.1 Company Overview
  9. 9. 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Strategic Overview 8.7.5 Recent Developments 8.8 F. Hoffmann-La Roche Ltd 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Strategic Overview 8.8.5 Recent Developments 8.9 Fresenius Medical Care AG & Co. Kgaa 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Strategic Overview 8.9.5 Recent Developments 8.10 Gambro AB 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Strategic Overview 8.10.5 Recent Developments 8.11 Iwalk, Inc. 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Strategic Overview
  10. 10. 8.11.5 Recent Developments 8.12 Jarvik Heart, Inc. 8.12.1 Company Overview Browse the full report at http://www.transparencymarketresearch.com/artificial- vital-organs-medical-bionics.html 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Strategic Overview 8.12.5 Recent Developments 8.13 Medtronic, Inc. 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Strategic Overview 8.13.5 Recent Developments 8.14 Micromed Cardiovascular, Inc. 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio 8.14.4 Strategic Overview 8.14.5 Recent Developments 8.15 Nikkiso Co., Ltd. 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio 8.15.4 Strategic Overview
  11. 11. 8.15.5 Recent Developments 8.16 Ossur Hf 8.16.1 Company Overview 8.16.2 Financial Overview 8.16.3 Product Portfolio 8.16.4 Strategic Overview 8.16.5 Recent Developments 8.17 Ottobock Healthcare Gmbh 8.17.1 Company Overview 8.17.2 Financial Overview 8.17.3 Product Portfolio 8.17.4 Strategic Overview 8.17.5 Recent Developments 8.18 Second Sight Medical Products, Inc. 8.18.1 Company Overview 8.18.2 Financial Overview 8.18.3 Product Portfolio 8.18.4 Strategic Overview 8.18.5 Recent Developments 8.19 Syncardia Systems, Inc. 8.19.1 Company Overview 8.19.2 Financial Overview 8.19.3 Product Portfolio 8.19.4 Strategic Overview 8.19.5 Recent Developments 8.20 Thoratec Corporation 8.20.1 Company Overview
  12. 12. 8.20.2 Financial Overview 8.20.3 Product Portfolio 8.20.4 Strategic Overview 8.20.5 Recent Developments 8.21 Touch Bionics, Inc. 8.21.1 Company Overview 8.21.2 Financial Overview 8.21.3 Product Portfolio 8.21.4 Strategic Overview 8.21.5 Recent Developments 8.22 Vital Therapies, Inc. 8.22.1 Company Overview 8.22.2 Financial Overview 8.22.3 Product Portfolio 8.22.4 Strategic Overview 8.22.5 Recent Developments 8.23 Worldheart Corporation 8.23.1 Company Overview 8.23.2 Financial Overview 8.23.3 Product Portfolio 8.23.4 Strategic Overview 8.23.5 Recent Developments About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.
  13. 13. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

×